BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• LimFlow Raises $40 Million (€36 Million) in Series D Financing

  LimFlow SA today announced it has closed a $40 million (€36 million) oversubscribed Series D financing round.

  April 5, 2022

   · 

  4 min read
• Business

  Ingersoll Rand Schedules First-Quarter 2022 Earnings Release and Conference Call

  Ingersoll Rand Inc. will issue its first-quarter earnings release after the market closes on May 4, 2022.

  April 5, 2022

   · 

  1 min read
• BioCapital

  NextCure to Present at 21st Annual Needham Virtual Healthcare Conference

  NextCure, Inc. announced that it will present at the 21st Annual Needham Virtual Healthcare Conference on Tuesday, April 12th at 3 pm ET.

  April 5, 2022

   · 

  2 min read
• Business

  MBX Biosciences Appoints Ora Hirsch Pescovitz, M.D., to Board of Directors

  MBX Biosciences, Inc., a clinical stage biopharmaceutical company developing peptide therapeutics with a focus on the treatment of endocrine disorders, announced the appointment of Ora Hirsch Pescovitz, M.D., to its Board of Directors.

  April 5, 2022

   · 

  2 min read
• Pharm Country

  Outlook Therapeutics to Present at Wet AMD and DME Drug Development Summit

  Outlook Therapeutics, Inc. announced that Russ Trenary, President and Chief Executive Officer of Outlook Therapeutics, will be presenting at the Wet AMD and DME Drug Development Summit taking place April 5-7, 2022 in Boston, Massachusetts.

  April 5, 2022

   · 

  1 min read
• Drug Development

  Mersana Therapeutics to Present Preclinical Data on XMT-1660, XMT-2056 and the Immunosynthen Platform at AACR Annual Meeting

  Mersana Therapeutics, Inc. today announced that it will present three posters highlighting data for XMT-1660, XMT-2056, and the Immunosynthen ADC platform at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2022 to be held in New Orleans, Louisiana from April 8-13, 2022.

  April 5, 2022

   · 

  7 min read
• Business

  OncoHost Announces Clinical Trial Collaboration with Roswell Park Comprehensive Cancer Center to Analyze Immunotherapy Resistance

  OncoHost announced today that Roswell Park Comprehensive Cancer Center has joined its PROPHETIC study, launching a clinical site in Buffalo, New York.

  April 5, 2022

   · 

  3 min read
• Drug Development

  Respira Therapeutics Announces First Patient Dosed in Phase 2b VIPAH-PRN 2b Trial of RT234 in Patients with Pulmonary Arterial Hypertension (PAH)

  Respira Therapeutics, Inc. announced today that the first patient in the United States has been dosed in the multicenter trial of its lead product candidate, RT234-PAH (vardenafil administered as a dry powder inhaled treatment).

  April 5, 2022

   · 

  4 min read
• Genetown

  Curis to Present at 21st Annual Needham Virtual Healthcare Conference

  Curis, Inc. today announced that James Dentzer , President and Chief Executive Officer of Curis, will present a company overview at the 21st Annual Needham Virtual Healthcare Conference.

  April 5, 2022

   · 

  1 min read
• Business

  Michael Krams, M.D., Joins Exscientia as Chief Quantitative Medicine Officer

  Exscientia plc (Nasdaq: EXAI) today announced the appointment of Michael Krams, M.D., as its Chief Quantitative Medicine Officer.

  April 5, 2022

   · 

  4 min read